Delivery Order SPE2DB20D3101-SPE2DB25FRWD5
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,608.02 for Promethegan 25 mg suppositories (12-count units) with an ultimate completion date of July 7, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,400.08 to AmerisourceBergen Drug Corp for Promethegan 25 mg suppositories (12 count) on December 17, 2025, with completion scheduled for December 18, 2025. This is a firm fixed price, non-set-aside competitive award to be fulfilled at the vendor's Conshohocken, Pennsylvania facility. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen Drug Corp supplies a comprehensive range of...
- The Defense Logistics Agency awarded a $3,900.48 delivery order to AmerisourceBergen Drug Corp for Promethegan 25 mg suppositories (12 count) on September 24, 2025, with completion targeted for September 25, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,852.24 to AmerisourceBergen Drug Corp for Promethegan 25 mg suppositories (12-pack units) on December 19, 2025, with an ultimate completion date of December 22, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and will be performed at the contractor's Conshohocken, Pennsylvania location. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,746.59 to AmerisourceBergen Drug Corp for Promethegan 25 mg suppositories (12-count units) with a completion date of July 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a $1,782.98 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Promethegan 25 mg suppositories (12-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of August 15, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract action, this delivery order is issued under...
- The Defense Logistics Agency awarded a $2,767.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Promethegan 12.5 mg suppositories (12-count) on December 18, 2025, with completion scheduled for December 19, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement designated SPE2DX and running through December 2026. The order...
- The Defense Logistics Agency awarded a delivery order valued at $1,335.72 to AmerisourceBergen Drug Corp for Promethegan 25 mg suppositories (12 units) on September 5, 2025, with completion targeted for September 8, 2025. This firm fixed-price, non-set-aside contract is being performed at the vendor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, is fulfilling this order as a child...
- The Defense Logistics Agency awarded a $4,446.72 delivery order to AmerisourceBergen Drug Corp for Promethegan 25 mg suppositories (12 count) with a completion date of September 25, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, serves as the prime...
- The Defense Logistics Agency awarded a delivery order valued at $1,875.57 to AmerisourceBergen Drug Corp for Promethegan 12.5 mg suppositories (12 count), with an ultimate completion date of November 5, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRWD5Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,950.24 to AmerisourceBergen Drug Corp for Promethegan 25 mg suppositories (12-count units) on September 22, 2025, with completion scheduled for September 23, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract and leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle extending through December 2026 that serves as the primary pharmaceutical supply mechanism for military healthcare systems worldwide. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting Defense Health Agency and military healthcare operations. The company maintains an extensive portfolio of pharmaceutical and medical supply deliveries under the DLA Troop Support Medical contract, encompassing brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains. This delivery order for Promethegan suppositories represents a routine transactional award under the broader IDC vehicle, reflecting the company's ongoing role as a primary supplier within the DLA's pharmaceutical procurement framework for military health system requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 9/22/25 |